SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Wojcieszynski AP, Berman AT, Wan F, et al. The impact of radiation therapy sequencing on survival and cardiopulmonary mortality in the combined modality treatment of patients with esophageal cancer [published online ahead of print February 7, 2013]. Cancer. 2013.
  • 2
    Lv J, Cao XF, Zhu B, Ji L, Tao L, Wang DD. Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma. World J Gastroenterol. 2010;16:1649-1654.
  • 3
    Lally BE, Zelterman D, Colasanto JM, Haffty BG, Detterbeck FC, Wilson LD. Postoperative Radiotherapy for stage II or III non–small-cell lung cancer using the Surveillance, Epidemiology, and End Results database. J Clin Oncol. 2006;24: 2998-3006.
  • 4
    Wisnivesky JP, Halm EA, Bonomi M, Smith C, Mhango G, Bagiella E. Postoperative radiotherapy for elderly patients with stage III lung cancer. Cancer. 2012;118:4478-4485.
  • 5
    Malthaner R. Quality of Life in Neoadjuvant Versus Adjuvant Therapy of Esophageal Cancer Treatment Trial (QUINTETT) (ClinicalTrials.gov identifier NCT00907543). Available at: http://www.clinical trials.gov/ct2/show/NCT00907543. Accessed February 13, 2013.